MYERS ROBERT L 4

4 · Predictive Oncology Inc. · Filed Sep 9, 2020

Insider Transaction Report

Form 4

Period: 2020-09-04

Predictive Oncology Inc.POAI

MYERS ROBERT L

Chief Financial Officer

Transactions

Award
Stock Options (Right to buy)
2020-09-04+53→ 53 total
Exercise: $1.54Exp: 2022-08-13→ CommonStock (53 underlying)
Award
Stock Options (Right to buy)
2020-09-04+42→ 42 total
Exercise: $1.54Exp: 2023-08-29→ Common Stock (42 underlying)
Award
Stock Options (Right to buy)
2020-09-04+14→ 14 total
Exercise: $1.54Exp: 2024-03-07→ Common Stock (14 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−14→ 0 total
Exercise: $4312.50Exp: 2024-03-07→ Common Stock (14 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−357→ 0 total
Exercise: $41.98Exp: 2026-09-16→ Common Stock (357 underlying)
Award
Stock Options (Right to buy)
2020-09-04+30,411→ 30,411 total
Exercise: $1.54Exp: 2027-06-22→ Common Stock (30,411 underlying)
Award
Stock Options (right to buy)
2020-09-04+16,600→ 16,600 total
Exercise: $1.54Exp: 2029-04-04→ Common Stock (16,600 underlying)
Disposition to Issuer
Stock Options
2020-09-04−53→ 0 total
Exercise: $1500.00Exp: 2022-08-13→ Common Stock (53 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−42→ 0 total
Exercise: $1481.25Exp: 2023-08-29→ Common Stock (42 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−30,411→ 0 total
Exercise: $14.70Exp: 2027-06-22→ Common Stock (30,411 underlying)
Award
Stock Options (Right to buy)
2020-09-04+357→ 357 total
Exercise: $1.54Exp: 2026-09-16→ Common Stock (357 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−16,600→ 0 total
Exercise: $7.48Exp: 2029-04-04→ Common Stock (16,600 underlying)

Holdings

Common Stock
77

Footnotes (4)

[F1]All transactions reported on this form involve the repricing of stock options with an exercise price greater than $1.54 to an exercise price of $1.54, as approved by shareholders at the 2020 annual meeting, with certification of the shareholder vote as of September 4, 2020.
[F2]Currently exercisable.
[F3]12,450 shares are currently vested; 2,075 shares vest on each of 10/4/2020 and 1/4/2021.
[F4]Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on October 29, 2019.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -